MA47193A - Formes posologiques solides d'inhibiteurs bace1 2-amino-6-(difluorométhyl)-5,5-difluoro-6-phényl-3,4,5,6-tétrahydropyridine - Google Patents

Formes posologiques solides d'inhibiteurs bace1 2-amino-6-(difluorométhyl)-5,5-difluoro-6-phényl-3,4,5,6-tétrahydropyridine

Info

Publication number
MA47193A
MA47193A MA047193A MA47193A MA47193A MA 47193 A MA47193 A MA 47193A MA 047193 A MA047193 A MA 047193A MA 47193 A MA47193 A MA 47193A MA 47193 A MA47193 A MA 47193A
Authority
MA
Morocco
Prior art keywords
bace1
tetrahydropyridine
difluoromethyl
difluoro
phenyl
Prior art date
Application number
MA047193A
Other languages
English (en)
Inventor
Karsten Juhl
Mauro Marigo
Lena Tagmose
Original Assignee
H Lundbeck As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Lundbeck As filed Critical H Lundbeck As
Publication of MA47193A publication Critical patent/MA47193A/fr

Links

MA047193A 2014-11-10 2015-11-09 Formes posologiques solides d'inhibiteurs bace1 2-amino-6-(difluorométhyl)-5,5-difluoro-6-phényl-3,4,5,6-tétrahydropyridine MA47193A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA201400648 2014-11-10

Publications (1)

Publication Number Publication Date
MA47193A true MA47193A (fr) 2019-11-13

Family

ID=58688571

Family Applications (1)

Application Number Title Priority Date Filing Date
MA047193A MA47193A (fr) 2014-11-10 2015-11-09 Formes posologiques solides d'inhibiteurs bace1 2-amino-6-(difluorométhyl)-5,5-difluoro-6-phényl-3,4,5,6-tétrahydropyridine

Country Status (2)

Country Link
AR (1) AR102599A1 (fr)
MA (1) MA47193A (fr)

Also Published As

Publication number Publication date
AR102599A1 (es) 2017-03-08

Similar Documents

Publication Publication Date Title
NL301322I2 (nl) Repotrectinib en/of farmaceutisch aanvaardbare zouten daarvan
IL285114B1 (en) Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders
IL246833A0 (en) New salts and their pharmaceutical preparations for the treatment of inflammatory disorders
MA41265A (fr) Compositions pour administration de médicaments iléo-jéjunal.
EP3274440A4 (fr) Détection de troubles de l' sophage
DK3119397T3 (da) Heterocykliske forbindelser til anvendelse i behandling af PI3K-gamma-medierede lidelser
EP3174874A4 (fr) Sels de berbérine, sels ursodésoxycholiques et des combinaisons, des procédés de préparation et d'application correspondants
DK3102213T3 (da) Farmaceutiske sammensætninger til behandlingen af inflammatoriske lidelser
PL3936130T3 (pl) Schemat dawkowania walbenazyny w leczeniu hiperkinetycznych zaburzeń ruchu
IL252089A0 (en) 2-amino-6-(difluoromethyl)- 5,5-difluoro-6-phenyl-3,4,5,6-tetrahydropyridines as bace1 inhibitors
BR112016021012A2 (pt) composições farmacêuticas de compostos terapeuticamente ativos.
HUE037179T2 (hu) Gyógyászati kompozíciók izom-rendellenességek kezelésére
IL251859A0 (en) Methotrexate formulation
GB201401086D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
BR112017013012A2 (pt) compostos de indenil, composições farmacêuticas e usos médicos destes
PT3359146T (pt) Composições farmacêuticas e utilizações contra os distúrbios de armazenamento lisossómico
EP3344280A4 (fr) Formation d'os
PL3426230T3 (pl) Stałe postacie dawkowania wigabatryny
EP3387469A4 (fr) Détermination d'électrofaciès
LT3519050T (lt) Kompozicijos, skirtos oftalmologinių būklių gydymui
LT3244889T (lt) Farmacinė kompozicija, skirta mikozės gydymui
DK3423081T3 (da) Sammensætninger til brug i behandlingen af neurologisk sygdom
HUP1600415A2 (en) Pimavanserin salts for the manufacture of pharmaceutical formulations
LT3148588T (lt) N,n-bis-2-merkaptoetilizoftalamidas, skirtas parkinsono ligos gydymui
HRP20182018T1 (hr) Priprava krutog oblika gadobenat dimeglumina